Inozyme Pharma, a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, entered into a debt financing facility for up to $70 million with K2 HealthVentures (K2HV), a...
view press release
July 27, 2022, 08:00 AM
|
XOMA Corporation, a pioneer in the discovery, development and licensing of therapeutic antibodies, announced it has entered into a flexible $20 million credit facility with Silicon Valley Bank, with availability through March 2019.“This credit...
view press release
May 08, 2018, 08:01 AM
|
Boston Financial & Equity Corporation (BFEC) recently closed two transactions. One was for a “prepared meals to go” company, which is expanding from the Midwest to the East, and along with that growth is the need for packaging equipment. As an...
view press release
November 18, 2015, 07:01 AM
|
Relypsa, Inc., a biopharmaceutical company, announced it has secured a loan facility of up to $35 million with Oxford Finance LLC ("Oxford") and Silicon Valley Bank ("SVB").Under the terms of the agreement, the company immediately drew $15 million...
view press release
June 03, 2014, 07:19 AM
|
Monroe Capital announced the funding of a $46.5 million unitranche credit facility to support the recapitalization of Conisus, LLC by private equity sponsor, Webster Capital.
Based in Atlanta, GA, Conisus offers innovative, scientific-oriented...
view press release
January 08, 2013, 07:32 AM
|